Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers
Multimodal treatment can be considered in pediatric patients with peritoneal carcinomatosis. It presents a safe and feasible therapy with manageable complications and no perioperative mortality when performed by an experienced multidisciplinary team. Indication for CRS and HIPEC in children should be an individual decision by an interdisciplinary tumor board in the absence of better alternatives.
Authors
- Sebastian Blaj (ORCID: https://orcid.org/0000-0001-5830-9797)
- Jens Werner (ORCID: https://orcid.org/0000-0001-7156-4370)
- Pompiliu Piso (ORCID: https://orcid.org/0000-0001-7146-4505)
- Miklos Acs (ORCID: https://orcid.org/0000-0003-4706-5541)
- Niklas Bogovic
- Michael Gerken (ORCID: https://orcid.org/0000-0001-8610-9303)
- Matthias Hornung (ORCID: https://orcid.org/0000-0001-9759-8958)
- Hans J. Schlitt (ORCID: https://orcid.org/0000-0002-3874-0296)
- Ferdinand Füsi
- Marta Mendieta Eckert
Institutions
- Medical University of Graz (AT)
- Krankenhaus Barmherzige Brüder (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- Pleura and Peritoneum
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1515/pp-2025-0011
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00